Montelukast (brand name Singulair®) is a leukotriene receptor antagonist (LTRA) medication used to prevent asthma attacks. It comes with a black-box warning on potential life-threatening side effects like mental changes which can appear as agitation, hallucinations, and suicidal thoughts. Healthcare providers should always be aware and informed of the fact that Montelukast may raise the risk of neuropsychiatric disorders.
The correct answer is D.
Comments
Post a Comment